v3.24.1.u1
CONSOLIDATED BALANCE SHEETS - USD ($)
Feb. 29, 2024
Aug. 31, 2023
Current    
Cash $ 4,705,399 $ 1,352,102
Marketable securities 87,699 125,642
Accounts receivable 357,090 126,686
Prepaid expenses and other current assets 266,796 546,783
Total Current Assets 5,416,984 2,151,213
Non-current assets, net    
Long-term receivables 39,494 48,559
Right of use assets 149,997 167,446
Intellectual property, net 519,253 462,625
Property & equipment, net 226,315 254,143
Total Non-current Assets 935,059 932,773
TOTAL ASSETS 6,352,043 3,083,986
Current Liabilities    
Accounts payable and accrued liabilities 55,318 239,941
Lease liability, current 26,399 27,794
Total Current Liabilities 81,717 267,735
Lease liabilities - non-current 122,486 136,173
TOTAL LIABILITIES 204,203 403,908
Share Capital    
Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Common shares issued and outstanding: 12,387,673 and 8,091,650 at February 29, 2024 and August 31, 2023, respectively. 12,388 8,091
Additional paid-in capital 54,121,316 48,799,454
Accumulated Deficit (47,592,289) (45,763,427)
Accumulated other comprehensive income (20,626) 0
Equity attributable to shareholders of Lexaria 6,520,789 3,044,118
Non-controlling interest (372,949) (364,040)
Total Stockholders' Equity 6,147,840 2,680,078
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 6,352,043 $ 3,083,986

Source